Member Info for solstace

strong close coming!

16.75 should breach 20pps this afternoon easy! GLA

Nice gains to be had from here! GLA

Getting a wriggle on!

Sighs, this is no whete near the highs!!

I would wager its not an American company if it were Donald would have mentioned it by name a couple of thousand times!

If it was Remdesivir he would have said!

According to the RNS they had no previous notifiable holding.......

Snapped up 10% yesterday so chucked £20m+ into SNG on the back of that RNS at £2 or over!! They know what they are doing and will be expecting a BIG return on their investment!!
Underpins £2pps

30%

Get tweeting and Emailing the bloomberg video around the globe!

https://www.bloomberg.com/news/videos/2020-07-21/synairgen-seeks-fda-ema-engagement-on-covid-19-drug-video

Volume looks gooood :-)

https://www.independent.co.uk/news/health/coronavirus-treatment-synairgen-sng001-trials-a9628101.html

Of testing required globally this coming Flu season to differentiate between that and Covid is staggering! 10,000 test manufacturers couldnt meet the requirement running flat out production lines! GDR is going to be massive the same as ALL companies with quick, reliable, accurate tests!

The first problem will be figuring out which virus a patient has. Flu, Covid-19 and other seasonal respiratory diseases are virtually indistinguishable on the basis of symptoms, warns Barbara Rath of the University of Nottingham: even the loss of taste and smell many people get with Covid-19 is not unique. We need more and better diagnostic tests, she says, because the difference matters: medical staff need full protective gear to manage a Covid patient, but they can be vaccinated for flu.

Friday 24th 7am :-)

MM's keep a wide spread when news is inbound...........

Many times, sitting on a substantial loss! One RNS later and its gone full tilt the other way! Its hard watching at times, but if you you've done your research and know what your about then you shouldn't be too worried! GLA

GDR can match NCYT sales imop. Approvals and sales are incoming and will push the Mcap up into £100m+ range imop